Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int Orthop ; 40(11): 2393-2399, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27658412

ABSTRACT

PURPOSE: To determine various clinical, radiographic, and pathological parameters which may indicate an increased risk of Giant cell tumour of bone (GCTB) recurrence after surgical therapy. METHODS: The study included a total of 164 GCTB samples; 118 (72 %) primary tumours, and 46 (28 %) recurrences; which were analyzed on immunohistochemistry for expression of Ki67, p53, cyclin D1, and ß-catenin. RESULTS: Among 13 analyzed clinical, radiological, and histological variables, which presented possible predictive factors for the incidence of GCTB relapse, univariate logistic regression (ULR) extract three highly statistically significant parameters: 1) lesion localization, 2) nuclear p53 expression in mononuclear cells, and 3) nuclear cyclin D1 expression in giant multinuclear cells. The multivariate logistic regression (MLR), revealing that p53 expression in mononuclear cells was the most significant predictive factor (HR = 6,181 p < 0,001), the positivity of which indicated six times higher probability for recurrence in GCTB. The expression of cyclin D1 in giant cells, containing less than 15 nuclei, was also statistically significant (HR = 8,398, p = 0,038) for predicting the recurrence, and demonstrated eight times more frequent recurrence in positive tumours. CONCLUSIONS: This study confirmed independent predicting factors for GCTB reccurence: p53 expression in mononuclear tumour cells and cyclin D1 expression in giant multinuclear cells. Results are new addition to generally known parameters, such as: localization of lesion, number of surgical interventions, clear destruction of cortex with the presence of extracompartmental lesion, and histological criteria for malignancy and can help in further research and treatment of GCTB.


Subject(s)
Bone Neoplasms/metabolism , Cyclin D1/biosynthesis , Giant Cell Tumor of Bone/metabolism , Ki-67 Antigen/biosynthesis , Neoplasm Recurrence, Local/metabolism , Tumor Suppressor Protein p53/biosynthesis , beta Catenin/biosynthesis , Bone Neoplasms/surgery , Female , Giant Cell Tumor of Bone/surgery , Humans , Immunohistochemistry , Male , Registries
2.
Pol J Pathol ; 67(4): 345-350, 2016.
Article in English | MEDLINE | ID: mdl-28547961

ABSTRACT

Aim of the study is to determine the possible roles of p53, cyclin D1, ß-catenin and Ki-67 in the increase in risk of fractures in patients with giant cell tumor of bone. The study included a total of 164 patients with giant cell tumor of bone (GCTB), 21 (12.8%) with and 143 (87.2%) without fracture. The samples were analyzed immunohistochemically for expression of Ki-67, p53, cyclin D1 and ß-catenin. According to the immunohistochemical expression of p53 and Ki 67 in mononuclear stromal cells, as well as of cyclin D1 in multinuclear giant cells, there was no significant association with immunopositivity and risk of fractures. However, our research revealed that patients with cytoplasmic expression of b-catenin in stromal cells had three times more frequent occurrence of pathological fractures, which was highly statistically significant (χ2 = 7.065; p = 0.008). Moreover, a highly statistically significant correlation between the nuclear expression of ß-catenin in giant cells and the incidence of pathological fractures was also found (χ2 = 8.824; p = 0.003). The study showed that ß-catenin expression highly correlates with the incidence of pathological fractures in patients with GCTB. Taking into account that ß-catenin is closely linked to activation of the Wnt signaling pathway in GCTB pathogenesis, one could postulate that activation of the Wnt pathway is one of the contributing factors to locally destructive behavior of this tumor, as well as to the incidence of pathological fractures.


Subject(s)
Bone Neoplasms/complications , Fractures, Spontaneous/epidemiology , Giant Cell Tumor of Bone/complications , beta Catenin/biosynthesis , Adolescent , Adult , Biomarkers, Tumor/analysis , Bone Neoplasms/metabolism , Bone Neoplasms/pathology , Child , Child, Preschool , Female , Fractures, Spontaneous/etiology , Fractures, Spontaneous/metabolism , Giant Cell Tumor of Bone/metabolism , Giant Cell Tumor of Bone/pathology , Humans , Immunohistochemistry , Incidence , Male , Middle Aged , Young Adult , beta Catenin/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...